Development in Children Diagnosed with Congenital Muscular Torticollis
Launched by GAZI UNIVERSITY · Mar 13, 2025
Trial Information
Current as of April 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on understanding how congenital muscular torticollis, a condition where a child's head tilts to one side due to tight neck muscles, affects their motor development and sensory processing. Researchers believe that the way a child's head is positioned can impact their posture, movement, and overall development. By studying children with this condition, the goal is to gather important information that can help improve care and support for these young patients.
To be eligible for the study, infants aged between 0 and 12 months who have been diagnosed with congenital torticollis can participate, as long as their parents agree to it. However, children with serious genetic issues, major health problems, or vision and hearing difficulties will not be included. Families who join the study can expect a thorough evaluation of their child's motor skills and sensory processing, helping to ensure that children receive the best possible support as they grow. The trial is currently recruiting participants, and all genders are welcome to take part.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Infants diagnosed with congenital torticollis between 0-12 months of age,
- • with parental consent,
- Exclusion Criteria:
- • Children with chromosomal abnormalities,
- • serious congenital problems,
- • vision-hearing problem
- • children whose parents do not volunteer for the study will not be included in the study.
About Gazi University
Gazi University, a leading research institution based in Ankara, Turkey, is committed to advancing medical knowledge and improving patient care through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university integrates cutting-edge research with clinical practice to explore new therapeutic approaches and enhance existing treatments. Gazi University adheres to the highest ethical standards and regulatory guidelines, ensuring the integrity and safety of its clinical trials. By fostering partnerships with healthcare professionals and academic institutions, Gazi University aims to contribute significantly to the global scientific community and address pressing health challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ankara, , Turkey
Patients applied
Trial Officials
Rabia ZORLULAR
Principal Investigator
Gazi University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported